Demyelination

The short version: demyelination is a biological process, not a single disease, and the evidence here is almost entirely about how to see it on MRI, not about what causes it or how to stop it.

The evidence you have is a stack of imaging and diagnostic studies. One review describes how neuromyelitis optica (NMO) shows up on MRI, with long spinal cord lesions spanning three or more segments as a hallmark [1]. Another covers the corpus callosum patterns that help tell multiple sclerosis from NMO and other inflammatory diseases [2]. A case series describes nine patients with MOG-antibody disease, a separate demyelinating condition that can look like MS or NMO but has its own MRI features [7]. A pediatric NMO case report shows that anti-AQP4 antibodies are the diagnostic key [8]. A 2018 consensus paper defines radiologically isolated syndrome, meaning people with MS-like lesions on MRI who have never had symptoms [3]. A 2020 study found that 3D-FLAIR MRI detects about 40% more brain lesions than older sequences, especially near the cortex [4].

What is missing from this retrieval is almost everything a patient would want to know. There is no study here on what triggers demyelination in the first place. No trial of a dietary or lifestyle intervention. No data on the role of infections, toxins, or vaccine-triggered autoimmunity. One 2013 study found that higher LDL cholesterol was linked to more new MRI lesions over 24 months in people with a first demyelinating event [5], but that is a correlation, not a cause. The 2025 review of Guillain-Barre syndrome [6] is the only evidence here about a demyelinating condition of the peripheral nerves, and it focuses on treatment (IVIg and plasma exchange work equally well, steroids do not help), not on prevention or root cause.

The mechanism question is the one the establishment does not study. Demyelination is the stripping of the myelin sheath that insulates nerve fibers. In the colloidal frame, this is a surface-charge problem: myelin is a lipid-rich structure whose stability depends on zeta potential. When blood sludges, when inflammation disrupts the glycocalyx, when immune complexes or aluminum particles alter surface charge, the myelin becomes vulnerable to attack. The cell danger response, once triggered, can become chronic and self-sustaining. The evidence here does not test this frame, but it is consistent with it: the same inflammatory cascades that show up as MRI lesions are the ones that destabilize colloidal systems.

My call: the evidence here tells you how doctors look for demyelination, not what causes it or how to reverse it. If you or your child have a demyelinating diagnosis, the imaging data is solid, but the treatment evidence is limited to immunosuppression and symptom management. The root-cause questions have not been studied with the rigor they deserve. Confidence: high on the diagnostic imaging data, low on the evidence for cause and cure.